Ainos(AIMD)
搜索文档
Ainos(AIMD) - 2020 Q3 - Quarterly Report
2020-11-14 06:19
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [√] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from____to____ Commission File No. 0-20791 AMARILLO BIOSCIENCES, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction o ...
Ainos(AIMD) - 2020 Q2 - Quarterly Report
2020-08-13 03:43
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________ FORM 10-Q _____________________________ (Mark One) [√] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from____to____ Commission File No. 0-20791 _____________________________ AMARILLO BIOSCIENCES, INC. ...
Ainos(AIMD) - 2020 Q1 - Quarterly Report
2020-05-15 23:39
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [√] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from____to____ Commission File No. 0-20791 AMARILLO BIOSCIENCES, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of in ...
Ainos(AIMD) - 2019 Q4 - Annual Report
2020-03-31 05:06
U.S. Securities and Exchange Commission Washington, D.C. 20549 FORM 10-K | --- | --- | |-----------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------| | | | | Annual Report Pursuant to Section 13 Act of 1934 [Fee For the Fiscal Year Ended | or 15(d) of the Securities Exchange Required] December 31, 2019 | | Transition Report Under Section 13 or Act of 1934 [No | 15(d) of the Secu ...
Ainos(AIMD) - 2019 Q3 - Quarterly Report
2019-11-14 04:17
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [√] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 Or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____to___ Commission File No. 0-20791 AMARILLO BIOSCIENCES, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction o ...
Ainos(AIMD) - 2019 Q2 - Quarterly Report
2019-08-10 05:28
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________ FORM 10-Q __________________________ (Mark One) [√] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from____to____ Commission File No. 0-20791 __________________________ AMARILLO BIOSCIENCES, INC. (Exact na ...